1. Panels
  2. Breast cancer pertinent cancer susceptibility
The latest signed off version for the GMS is v2.0. The current version, shown here, may differ from the signed-off version.

Breast cancer pertinent cancer susceptibility (Version 2.16)

Level 2: Cancer susceptibility

Relevant disorders: Breast
Panel types: Cancer Germline 100K, GMS Cancer Germline Virtual, GMS signed-off
Latest signed off version: v2.0 (22 Mar 2023)
Previously signed off versions: v1.1
Previous code: 596f82e88f620352d0e3eeb1
Description
This panel is used for clinical indications in the NHS Genomic Medicine Service. It is also used for participants in the Cancer programme of the 100,000 Genomes Project.

Further information on the testing criteria and any overlapping clinical indications can be found within the 'National Genomic Test Directory for cancer' document at: https://www.england.nhs.uk/publication/national-genomic-test-directories/.

A version of this panel has been signed off under NHS Genomic Medicine Service governance (see 'Latest signed off version' in the panel header information).

General Information:

-The National Genomic Test Directory for Cancer has been developed under the guidance of NHS England's Cancer experts.

-Please contact your Genomic Laboratory Hub for information regarding specific queries. More information about Genomic Laboratory Hubs can be found here: https://www.england.nhs.uk/genomics/genomic-laboratory-hubs/

-This panel was originally developed for the 100,000 Genomes Project and is still being used for participants in the project. For the Cancer programme eligibility criteria refer to: https://www.genomicsengland.co.uk/cancer-programme/eligibility/
Panel Activity

6 reviewers

  • Ellen McDonagh (Genomics England Curator)

    Group: Other
    Workplace: Other

  • Clare Turnbull (Queen Mary University London)

    Group: GeCIP domain
    Workplace: NHS clinical service

  • Dmitrijs Rots (Children's Clinical University Hospital)

    Group: Other
    Workplace: Research lab

  • Catherine Snow (Genomics England)

    Group: Other
    Workplace: Other

  • Arina Puzriakova (Genomics England Curator)

    Group: Other
    Workplace: Other

  • Lauma Freimane (Children's Clinical University Hospital)

    Group: Other
    Workplace: Other diagnostic lab

7 Entities

7 reviewed, 4 green

List Entity Reviews Mode of inheritance Details
7 Entitiess
Green List (high evidence)
BRCA1
3 reviews
1 green
BOTH monoallelic and biallelic, autosomal or pseudoautosomal
Sources
  • Expert list
  • Expert Review Green
  • NHS GMS
Phenotypes
  • {Breast-ovarian cancer, familial, 1}, OMIM:604370
Tags
Green List (high evidence)
BRCA2
2 reviews
1 green
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Sources
  • Expert list
  • Expert Review Green
Phenotypes
  • {Breast-ovarian cancer, familial, 2}, OMIM:612555
  • {Breast cancer, male, susceptibility to}, OMIM:114480
Tags
Green List (high evidence)
PALB2
2 reviews
1 green
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Sources
  • Expert list
  • Expert Review Green
Phenotypes
  • Breast cancer
Tags
Green List (high evidence)
TP53
2 reviews
1 green
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Sources
  • Expert list
  • Expert Review Green
Phenotypes
  • Breast cancer
Tags
Amber List (moderate evidence)
ATRIP
3 reviews
2 green
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Sources
  • Expert Review Amber
  • Literature
Phenotypes
  • Hereditary breast cancer
Tags
Amber List (moderate evidence)
CDH1
3 reviews
1 green
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Sources
  • Expert Review Amber
  • Literature
Phenotypes
  • Diffuse gastric and lobular breast cancer syndrome with or without cleft lip and/or palate, OMIM:137215
Tags
Amber List (moderate evidence)
PTEN
5 reviews
2 green
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Sources
  • Expert list
  • Expert Review Amber
Phenotypes
  • Breast cancer
Tags
  • Q2_25_expert_review
  • Q2_25_ promote_green

Major version comments

  • 2023-03-22 16:27 Catherine Snow (Genomics England) promoted panel to 2.0
    The content of this panel has been updated in accordance with changes agreed with the NHS Genomic Medicine Service. The panel was promoted to the next major version (2.0) following this.

    2018-09-07 12:14 Louise Daugherty (Genomics England Curator) promoted panel to 1.0
    This Cancer Germline 100K panel has been subjected to extensive internal and external review and has been versioned to V1 to enable germline reporting in the Cancer Pipeline.

Downloads

Download lists

  • Whole panel
  • Green list (high evidence)
  • Green and Amber Genes
  • Amber Genes
  • Red list (low evidence)

Download Version